Left ventricular assist device-related infections: past, present and future

References

• Roger VL, Go AS, Lloyd-Jones DM et al. Heart Disease and Stroke Statistics – 2011 Update: a report from the American Heart Association. Circulation123(4), e18–e209 (2010).
   Google Scholar
• Stehlik J, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report – 2010. J. Heart Lung Transplant.29(10), 1089–1103 (2010).
   PubMed Web of Science ®Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med.345(20), 1435–1443 (2001).
   PubMed Web of Science ®Google Scholar
• Pagani FD, Miller LW, Russell SD et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J. Am. Coll. Cardiol.54(4), 312–321 (2009).
   PubMed Web of Science ®Google Scholar
• Slaughter MS, Rogers JG, Milano CA et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med.361(23), 2241–2251 (2009).
   PubMed Web of Science ®Google Scholar
• Oz MC, Gelijns AC, Miller L et al. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann. Surg.238(4), 577–583 (2003).
   PubMed Web of Science ®Google Scholar
• Chinn R, Dembitsky W, Eaton L et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J.51(4), 461–470 (2005).
   PubMed Web of Science ®Google Scholar
• Holman WL, Rayburn BK, McGiffin DC et al. Infection in ventricular assist devices: prevention and treatment. Ann. Thorac. Surg.75(6 Suppl.), S48–S57 (2003).
   PubMed Web of Science ®Google Scholar
• Litzler PY, Manrique A, Etienne M et al. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J. Nucl. Med.51(7), 1044–1048 (2010).
   Google Scholar
• Topkara VK, Dang NC, Martens TP et al. Bridging to transplantation with left ventricular assist devices: outcomes in patients aged 60 years and older. J. Thorac. Cardiovasc. Surg.130(3), 881–882 (2005).
   Google Scholar
• Huang R, Deng M, Rogers JG et al. Effect of age on outcomes after left ventricular assist device placement. Transplant. Proc.38(5), 1496–1498 (2006).
   PubMed Web of Science ®Google Scholar
• Morgan JA, Weinberg AD, Hollingsworth KW, Flannery MR, Oz MC, Naka Y. Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devices. J. Thorac. Cardiovasc. Surg.127(4), 1193–1195 (2004).
   Google Scholar
• Dang NC, Topkara VK, Kim BT, Oz MC, Naka Y. Effect of race on outcomes in patients with left ventricular assist devices (LVADs). ASAIO J.50(2), 148 (2004).
   Google Scholar
• Topkara VK, Kondareddy S, Malik F et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann. Thorac. Surg.90(4), 1270–1277 (2010).
   PubMed Web of Science ®Google Scholar
• Schaffer JM, Allen JG, Weiss ES et al. Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. J. Heart Lung Transplant.30(2), 164–174 (2011).
   PubMed Web of Science ®Google Scholar
• Topkara VK, Dang NC, Martens TP et al. Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation. J. Heart Lung Transplant.24(12), 2048–2053 (2005).
   Google Scholar
• Butler J, Howser R, Portner PM, Pierson RN 3rd. Diabetes and outcomes after left ventricular assist device placement. J. Card. Fail.11(7), 510–515 (2005).
   Google Scholar
• Uriel N, Naka Y, Colombo PC et al. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur. J. Heart Fail.13(2), 195–199 (2011).
   PubMedGoogle Scholar
• Raymond AL, Kfoury AG, Bishop CJ et al. Obesity and left ventricular assist device driveline exit site infection. ASAIO J.56(1), 57–60 (2010).
   PubMed Web of Science ®Google Scholar
• Butler J, Howser R, Portner PM, Pierson RN 3rd. Body mass index and outcomes after left ventricular assist device placement. Ann. Thorac. Surg.79(1), 66–73 (2005).
   PubMed Web of Science ®Google Scholar
• Martin SI, Wellington L, Stevenson KB et al. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact. Cardiovasc. Thorac. Surg.11(1), 20–23 (2010).
   PubMedGoogle Scholar
• Holdy K, Dembitsky W, Eaton LL et al. Nutrition assessment and management of left ventricular assist device patients. J. Heart Lung Transplant.24(10), 1690–1696 (2005).
   PubMed Web of Science ®Google Scholar
• Kimball PM, Flattery M, McDougan F, Kasirajan V. Cellular immunity impaired among patients on left ventricular assist device for 6 months. Ann. Thorac. Surg.85(5), 1656–1661 (2008).
   PubMedGoogle Scholar
• Dang NC, Topkara VK, Kim BT, Lee BJ, Remoli R, Naka Y. Nutritional status in patients on left ventricular assist device support. J. Thorac. Cardiovasc. Surg.130(5), e3–e4 (2005).
   Google Scholar
• Schulman AR, Martens TP, Christos PJ et al. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J. Thorac. Cardiovasc. Surg.133(3), 841–842 (2007).
   PubMed Web of Science ®Google Scholar
• Milano CA, Naftel DC, Padera RF et al. Infection during mechanical circulatory support: can we really expect a better outlook with continuous flow technology. J. Heart Lung Transplant.29(2), S52 (2010) (Abstract).
   Google Scholar
• Aaronson KD, Slaughter MS, McGee E et al. Evaluation of the HeartWare® HVAD Left Ventricular Assist Device System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge to Transplant Trial. Circulation122, 2215–2226 (2010) (Abstract).
   Google Scholar
• Zierer A, Melby SJ, Voeller RK et al. Late-onset driveline infections: the Achilles’ heel of prolonged left ventricular assist device support. Ann. Thorac. Surg.84(2), 515–520 (2007).
   PubMed Web of Science ®Google Scholar
• Ankersmit HJ, Edwards NM, Schuster M et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation100(19 Suppl.), II211–II215 (1999).
   Google Scholar
• Ankersmit HJ, Tugulea S, Spanier T et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet354(9178), 550–555 (1999).
   PubMedGoogle Scholar
• Kimball PM, Flattery M, McDougan F, Kasirajan V. Cellular immunity impaired among patients on left ventricular assist device for 6 months. Ann. Thorac. Surg.85(5), 1656–1661 (2008).
   PubMedGoogle Scholar
• Kimball P, Flattery M, Kasirajan V. T-cell response to staphylococcal enterotoxin B is reduced among heart failure patients on ventricular device support. Transplant. Proc.38(10), 3695–3696 (2006).
   Google Scholar
• Schuster M, Kocher A, John R et al. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum. Immunol.63(3), 211–220 (2002).
   Google Scholar
• Ankersmit HJ, Wieselthaler G, Moser B et al. Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. J. Thorac. Cardiovasc. Surg.123(3), 557–561 (2002).
   Google Scholar
• Simon D, Fischer S, Grossman A et al. Left ventricular assist device-related infection: treatment and outcome. Clin. Infect. Dis.40(8), 1108–1115 (2005).
   PubMed Web of Science ®Google Scholar
• Monkowski DH, Axelrod P, Fekete T, Hollander T, Furukawa S, Samuel R. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl. Infect. Dis.9(2), 114–120 (2007).
   PubMed Web of Science ®Google Scholar
• Nurozler F, Argenziano M, Oz MC, Naka Y. Fungal left ventricular assist device endocarditis. Ann. Thorac. Surg.71(2), 614–618 (2001).
   PubMed Web of Science ®Google Scholar
• Baradarian S, Stahovich M, Krause S, Adamson R, Dembitsky W. Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J.52(3), 354–356 (2006).
   Google Scholar
• Garatti A, Giuseppe B, Russo CF, Marco O, Ettore V. Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy. J. Heart Lung Transplant.26(9), 956–959 (2007).
   Google Scholar
• McKellar SH, Allred BD, Marks JD et al. Treatment of infected left ventricular assist device using antibiotic-impregnated beads. Ann. Thorac. Surg.67(2), 554–555 (1999).
   Google Scholar
• Tjan TD, Asfour B, Hammel D, Schmidt C, Scheld HH, Schmid C. Wound complications after left ventricular assist device implantation. Ann. Thorac. Surg.70(2), 538–541 (2000).
   Google Scholar
• Hutchinson OZ, Oz MC, Ascherman JA. The use of muscle flaps to treat left ventricular assist device infections. Plast. Reconstr. Surg.107(2), 364–373 (2001).
   Google Scholar
• Sajjadian A, Valerio IL, Acurturk O et al. Omental transposition flap for salvage of ventricular assist devices. Plast. Reconstr. Surg.118(4), 919–926 (2006).
   Google Scholar
• Holman WL, Park SJ, Long JW et al. Infection in permanent circulatory support: experience from the REMATCH trial. J. Heart Lung Transplant.23(12), 1359–1365 (2004).
   PubMed Web of Science ®Google Scholar
• Sinha P, Chen JM, Flannery M, Scully BE, Oz MC, Edwards NM. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation102(19 Suppl. 3), III194–III199 (2000).
   PubMed Web of Science ®Google Scholar
• Schulman AR, Martens TP, Russo MJ et al. Effect of left ventricular assist device infection on post-transplant outcomes. J. Heart Lung Transplant.28(3), 237–242 (2009).
   PubMed Web of Science ®Google Scholar
• Williams MR, Oz MC. Indications and patient selection for mechanical ventricular assistance. Ann. Thorac. Surg.71(3 Suppl.), S86–S91 (2001).
   Google Scholar
• Schaffer JM, Allen JG, Weiss ES et al. Evaluation of risk indices in continuous-flow left ventricular assist device patients. Ann. Thorac. Surg.88(6), 1889–1896 (2009).
   PubMed Web of Science ®Google Scholar
• Pae WE, Connell JM, Adelowo A et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J. Heart Lung Transplant.26(3), 219–229 (2007).
   PubMed Web of Science ®Google Scholar
• Miller LW, Pagani FD, Russell SD et al. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med.357(9), 885–896 (2007).
   PubMed Web of Science ®Google Scholar
• Holman WL, Kirklin JK, Naftel DC et al. Infection after implantation of pulsatile mechanical circulatory support devices. J. Thorac. Cardiovasc. Surg.139(6), 1632–1636 (2010).
   PubMed Web of Science ®Google Scholar
• Herrmann M, Weyand M, Greshake B et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation95(4), 814–817 (1997).
   PubMed Web of Science ®Google Scholar
• Gordon SM, Schmitt SK, Jacobs M et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann. Thorac. Surg.72(3), 725–730 (2001).
   PubMed Web of Science ®Google Scholar